In this issue:
Cutaneous reactions after Moderna and Pfizer COVID-19 vaccination
Adalimumab originator vs biosimilar in patients with psoriasis
Infliximab originator vs biosimilar in patients with hidradenitis suppurativa
Topical calcineurin inhibitors and phototherapy for vitiligo do not increase skin cancer risk
Safety of low-dose oral minoxidil for hair loss
Rituximab vs mycophenolate mofetil in patients with pemphigus vulgaris
Air pollution and atopic dermatitis
Liver disease risk in patients taking methotrexate for various indications
Incomplete surgical excision of non-melanoma skin cancers
Risk factors for melanoma by anatomical site
Please login below to download this issue (PDF)